Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments

A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers

(2012) Karthik Venkatakrishnan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

(2012) Stefano Ferrari et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

(2011) J. S. Whelan et al.   ANNALS OF ONCOLOGY

Mifamurtide for the treatment of nonmetastatic osteosarcoma

(2011) Kosei Ando et al.   EXPERT OPINION ON PHARMACOTHERAPY

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group

(2010) C. A. S. Arndt et al.   CLINICAL CANCER RESEARCH

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

(2010) Malcolm A. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects

(2010) Katherine A Janeway et al.   LANCET ONCOLOGY

Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma

(2010) Colin Moore et al.   PEDIATRIC BLOOD & CANCER

Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma

(2010) Cristina Meazza et al.   PEDIATRIC BLOOD & CANCER

COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION

(2010) Winston W. Huh et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Mifamurtide

(2010) James E. Frampton   PEDIATRIC DRUGS

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

(2009) Alexander J. Chou et al.   CANCER

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Novel therapeutic agents for osteosarcoma

(2009) Kathleen O’Day et al.   Expert Review of Anticancer Therapy

Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma

(2009) Paul A Meyers   Expert Review of Anticancer Therapy

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

(2008) Paul A. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY

Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients

(2008) Stefan S. Bielack et al.   JOURNAL OF CLINICAL ONCOLOGY

Ototoxicity in children treated for osteosarcoma

(2008) Matthew J. Lewis et al.   PEDIATRIC BLOOD & CANCER